Free List Of Top 10 Active Pharmaceutical Ingredients Manufacturing Companies

The United States is home to some of the leading active pharmaceutical ingredients (API) manufacturing companies in the world. These companies play a pivotal role in the pharmaceutical and healthcare industry, producing essential components for medications and treatments. From established giants to innovative startups, the US API manufacturing sector continues to thrive, driving innovation and advancements in pharmaceuticals.

Introducing the Top 10 API Manufacturing Companies

1. Merck & Co., Inc.

– Sector: Pharmaceutical

– Year Founded: 1891

– Annual Revenue: $48 billion (2020)

– Description: Merck & Co., known as MSD outside the United States and Canada, is a global healthcare leader, producing a wide range of pharmaceuticals, including APIs for life-saving medications.

– Link: [Merck & Co., Inc.](https://www.merck.com)

2. Pfizer Inc.

– Sector: Pharmaceutical

– Year Founded: 1849

– Annual Revenue: $41.9 billion (2020)

– Description: Pfizer is a renowned pharmaceutical company engaged in the production of various APIs for its diverse portfolio of prescription drugs and vaccines.

– Link: [Pfizer Inc.](https://www.pfizer.com)

3. Johnson & Johnson

– Sector: Pharmaceutical and Medical Devices

– Year Founded: 1886

– Annual Revenue: $82.6 billion (2020)

– Description: Johnson & Johnson is a global leader in healthcare, manufacturing APIs for a wide array of pharmaceutical and medical products.

– Link: [Johnson & Johnson](https://www.jnj.com)

4. Bristol Myers Squibb

– Sector: Pharmaceutical

– Year Founded: 1858

– Annual Revenue: $42.5 billion (2020)

– Description: Bristol Myers Squibb focuses on developing and manufacturing APIs for innovative medicines in various therapeutic areas.

– Link: [Bristol Myers Squibb](https://www.bms.com)

5. AbbVie Inc.

– Sector: Biopharmaceutical

– Year Founded: 2013

– Annual Revenue: $45.8 billion (2020)

– Description: AbbVie is a cutting-edge biopharmaceutical company involved in the development and manufacturing of APIs for advanced therapies and treatments.

– Link: [AbbVie Inc.](https://www.abbvie.com)

6. Amgen Inc.

– Sector: Biotechnology

– Year Founded: 1980

– Annual Revenue: $25.4 billion (2020)

– Description: Amgen is a pioneer in biotechnology, producing APIs for a wide range of therapeutics, including biologic medications.

– Link: [Amgen Inc.](https://www.amgen.com)

7. Eli Lilly and Company

– Sector: Pharmaceutical

– Year Founded: 1876

– Annual Revenue: $24.5 billion (2020)

– Description: Eli Lilly is a leading pharmaceutical firm specializing in the development and manufacturing of APIs for an extensive lineup of medications.

– Link: [Eli Lilly and Company](https://www.lilly.com)

8. Gilead Sciences, Inc.

– Sector: Biopharmaceutical

– Year Founded: 1987

– Annual Revenue: $24.7 billion (2020)

– Description: Gilead Sciences is known for producing APIs for innovative therapeutics, particularly in the areas of antiviral and oncology treatments.

– Link: [Gilead Sciences, Inc.](https://www.gilead.com)

9. Pfizer CentreOne

– Sector: Contract Manufacturing

– Year Founded: 1849

– Annual Revenue: Part of Pfizer Inc.

– Description: Pfizer CentreOne operates as a contract manufacturing organization, providing API manufacturing services to a wide range of pharmaceutical clients globally.

– Link: [Pfizer CentreOne](https://www.pfizercentreone.com)

10. Lonza Group

– Sector: Contract Development and Manufacturing

– Year Founded: 1897

– Annual Revenue: $6.3 billion (2020)

– Description: Lonza offers API manufacturing and contract development services, catering to the pharmaceutical and biotechnology industries.

– Link: [Lonza Group](https://www.lonza.com)

Closing ideas

The API manufacturing industry in the United States is characterized by innovation, state-of-the-art technology, and a commitment to enhancing global healthcare. The top 10 companies listed above have demonstrated leadership in producing high-quality pharmaceutical ingredients, contributing significantly to the growth and development of the pharmaceutical sector. Their dedication to manufacturing APIs has been instrumental in advancing medical treatments, improving patient outcomes, and addressing diverse healthcare needs.